Phosphatidylethanolamine‐Binding Protein 1 (PEBP1) as a Potential Target for the Treatment for Depression

Saved in:

Bibliographic Details
Published in	CNS neuroscience & therapeutics Vol. 19; no. 12; pp. 982 - 983
Main Authors	Sun, Yang, Luo, Zhu‐Min, Zheng, Min‐Jun, Liu, Xia
Format	Journal Article
Language	English
Published	Oxford Wiley-Blackwell 01.12.2013 John Wiley & Sons, Inc John Wiley and Sons Inc
Subjects	Adult and adolescent clinical studies Animals Biological and medical sciences Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Depression Depression - drug therapy Depression - metabolism Depression - pathology Disease Models, Animal Electrodiagnosis. Electric activity recording Electrophoresis, Gel, Two-Dimensional Gene Expression Regulation - physiology Hippocampus - metabolism Investigative techniques, diagnostic techniques (general aspects) Letter to the Editor Letters to the Editor Macaca fascicularis Medical sciences Miscellaneous Mood disorders Nervous system Neurology Phosphatidylethanolamine Binding Protein - genetics Phosphatidylethanolamine Binding Protein - metabolism Phosphorylation Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry RNA, Messenger - metabolism Serine - metabolism Mood disorder Binding protein Depression Treatment
Online Access	Get full text

Loading…

More Information
Bibliography:	SourceType-Other Sources-1 ObjectType-Article-2 content type line 63 ObjectType-Correspondence-1 The first two authors contributed equally to this work.
ISSN:	1755-5930 1755-5949
DOI:	10.1111/cns.12185